WHITE PLAINS, NY, Jan. 28 /CNW/ - ORTHOMETRIX, INC. (OTCBB: OMRX)
announced today that its VibraFlex(R) series of whole body vibration
technologies and devices received a Class II Medical Device License from
Health Canada and may now be sold in the Canadian market as a medical device.
The VibraFlex(R), developed using the internationally patented Galileo(R)
vibration technology, is manufactured in Germany by Novotec Medical GmbH with
sales and marketing in United States through Orthometrix and local Canadian
sales representation through Motion Health Inc.
"We are thrilled to receive this license from Health Canada and it
reinforces the documented outcomes for our technology," said Reynald Bonmati,
President and CEO for Orthometrix, Inc. "VibraFlex is the first whole body
vibration device to receive this license making us unique in the Canadian
market. This reinforces the safety and effectiveness of the VibraFlex and when
purchasing a whole body vibration device, we encourage our potential customers
to consider a licensed device such as the VibraFlex."
VibraFlex(R) is protected by a worldwide patent and has been the focal
point of whole body vibration therapy literature and research since 1996. The
VibraFlex(R) can help to improve individual's strength & power, flexibility &
range of motion, circulation, and hormone profiles without the constraints of
conventional exercise. Having two critical elements for effectiveness, a
functional teeter-totter pattern of vibration and the appropriate frequency
range, this innovative technology is available in home, professional, upper
body, and medical models.
"Our first priority is to ensure the hospital and medical community is
aware of the new license status and the many benefits the VibraFlex offers,"
said Judy Pedersen, President of Motion Health Inc. "Receiving this license
allows numerous hospitals and research centres to implement innovative
programs to benefit pediatric patients who suffer from a variety of genetic
and metabolic disorders. These clinicians and researchers are innovators in
their fields and would welcome the opportunity to share information on their
exciting projects," said Pedersen.
Use is not limited to pediatrics and many Canadians of various ages and
states of health can benefit from the VibraFlex(R). The 25 Hz speed of the
VibraFlex(R) produces 1,500 involuntary muscle contractions per minute
providing a very strong training effect. The VibraFlex(R) achieves this very
high repetition rate with little physical effort by the user and can therefore
deliver many more repetitions per unit time and per exercise session. There is
no stress on joints, ligaments, and tendons and it does not tax the
cardiovascular system. Training sessions of only 3-5 minutes, twice to three
times a week, produce measurable results.
"In Canada, we will continue to advance the use of whole body vibration
by offering individuals, businesses and medical professionals safe, reliable,
science based technologies and services to enhance quality of life goals. The
VibraFlex(R) is a revolutionary way to augment and enhance current training
and rehabilitation efforts of Canadians," says Bonmati.
For further information:
For further information: Reynald Bonmati, Orthometrix at 1-877-249-4229
or visit the company web site at www.orthometrix.net or www.vibraflex.com;
Judy Pedersen, Motion Health Inc. at (403) 241-0093 or visit the company web
site at www.motionhealth.ca